GlassScriptPhysician profile
Asha Kumari Pathak
NPI 1881907871
$6,343.14
in general payments reported to CMS, 2019-2025
7 companies · $4,949 in 2025
The $4,949 reported for 2025 was more than what 87% of Endocrinology, Diabetes & Metabolism providers received nationally (typical 2025 total: $506).
See the full distribution for Endocrinology, Diabetes & Metabolism
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $214 · 2021: $246 · 2022: $250 · 2023: $198 · 2024: $487 · 2025: $4,949.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Honoraria: $4,053 · Food and Beverage: $866 · Travel and Lodging: $683 · Education: $32.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Honoraria | $4,053.00 |
| Food and Beverage | $865.81 |
| Travel and Lodging | $682.52 |
| Education | $32.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Chiesi USA, INC. | $4,949.11 | 2025 | Mycapssa |
| Novo Nordisk INC | $504.08 | 2019-2023 | Sogroya |
| Medtronic, INC. | $357.69 | 2023-2024 | Minimed 780g, Inpen Smart Insulin Delivery System |
| Recordati_rare_diseases_inc. | $294.53 | 2024 | Signifor Lar, Isturisa |
| Bigfoot Biomedical INC | $120.69 | 2021 | |
| Pfizer INC. | $117.04 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Asha Pathak listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.